Bingham Farms, MI, June 12, 2020 – E.M.M.A. International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting, releases a new White Paper covering the impact that the COVID-19 pandemic has had on FDA regulatory policies.
COVID-19 has had an unparalleled impact on the medical device industry, and the FDA has had to take significant steps in order to react to the pandemic appropriately. Our White Paper, “The FDA’s Response to COVID-19” details all the new FDA regulatory policies and changes in light of the pandemic, and how it will impact your product and business. The White Paper will also dive into what the future of the medical device regulatory landscape looks like, as the industry adjusts to its new “normal”. Our White Paper details everything the medical device industry needs to know about the FDA and COVID-19, all conveniently located in one place.
“The COVID-19 pandemic has had such a sweeping impact on not only the med device industry regulations, but also on how firms conduct business and continue operations.” said Madison Wheeler, EMMA International’s Senior Quality Engineer. “This White Paper is meant as an all-inclusive COVID-19 resource for everyone in the industry.”
Be sure to download it to find all of the information your company will need to stay updated during these uncertain times.
EMMA International has been keeping up to date with all of the ever-changing policies and regulations during the pandemic. Our team has the expertise and experience to get your business through COVID-19; whether you are new to the industry, or an established medical device firm that needs help navigating the temporary policies, EMMA International is ready to support your business through this unprecedented time. Give us a call at 248-987-4497 or email us at info@emmainternational.com to get connected with our team of experts!
